Numerous studies have reported that CaMKII plays an important role in the development of cardiac hypertrophy through the activation of impaired gene expression of atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), beta-myosin heavy chain (β-MHC), and skeletal actin [32]. The gene discussed is NPPA; the disease is cardiac hypertrophy.